A lesson from Parkinson’s Disease: Clinical Features, Etiology, and Pathogenesis

Clinical Features of PD

Parkinson’s disease presents with a combination of motor and non-motor symptoms, making it a highly heterogeneous condition. The classical motor symptoms associated with PD are tremors, rigidity, and bradykinesia, often accompanied by postural instability as the disease progresses. However, many patients experience non-motor symptoms that can precede motor symptoms for years or even decades. These early symptoms, such as hyposmia (reduced sense of smell), constipation, and rapid eye movement (REM) sleep behavior disorder, suggest that PD may begin outside the central nervous system, possibly in the peripheral autonomic nervous system or the olfactory bulb, before spreading to the substantia nigra.

The prodromal or pre-motor phase of Parkinson’s disease can last for more than a decade. During this time, patients may experience symptoms like depression, constipation, fatigue, urinary dysfunction, and REM sleep disorders. These early signs are increasingly recognized as indicators of an elevated risk of developing PD. Studies have shown that individuals with tremors, balance problems, or constipation several years before diagnosis are more likely to be diagnosed with Parkinson’s disease later on. This prodromal phase is a crucial area of interest for researchers, as it may provide an optimal window for early therapeutic intervention before substantial dopaminergic neuron loss occurs.

The primary motor symptoms of PD include:

  • Resting tremor: Often described as a "pill-rolling" tremor, it usually starts in one hand and can spread to other parts of the body as the disease progresses.
  • Bradykinesia: This refers to the slowness of movement and is one of the most disabling symptoms of PD. It affects voluntary movements like walking and fine motor tasks, contributing to a reduced range of motion and difficulty with activities of daily living.
  • Rigidity: Increased muscle tone leads to stiffness and resistance to passive movement. It often presents as "cogwheel rigidity," where the muscle resists movement in a series of jerky motions.
  • Postural instability: A tendency to fall, which typically occurs later in the disease, is linked to impaired reflexes and balance.

Non-motor symptoms of PD are increasingly being recognized as equally significant, if not more so, than motor symptoms in terms of their impact on the quality of life. These symptoms include cognitive impairments, mood disorders (e.g., depression, anxiety), autonomic dysfunction (e.g., orthostatic hypotension, urinary incontinence, constipation), sleep disturbances, and sensory changes like impaired smell. Cognitive decline and dementia can develop in advanced stages, with dementia occurring in up to 83% of patients after 20 years of diagnosis. Psychosis, hallucinations, and delusions are also common in later stages, particularly as complications of long-term dopaminergic therapy.

The progression of PD varies between individuals, with some patients showing predominantly tremor-dominant symptoms, which are often less severe and respond better to treatment. Others may exhibit a non-tremor dominant form, characterized by more significant bradykinesia, rigidity, and postural instability, often accompanied by greater cognitive and psychiatric impairments. These different subtypes of PD may have distinct underlying pathophysiological mechanisms, contributing to the variability in disease course and prognosis.

As the disease advances, complications related to long-term levodopa use, such as motor fluctuations (the "on-off" phenomenon) and dyskinesias (involuntary movements), can become more difficult to manage. Non-motor symptoms also become more pronounced, with increased severity of cognitive decline, psychiatric disturbances, and autonomic dysfunction. Patients in advanced stages of PD may require increased care and assistance, with many ultimately requiring placement in nursing homes due to the combined impact of motor and non-motor symptoms.

Free lesson

This lesson is part of “Parkinson’s Disease: Clinical Features, Etiology, and Pathogenesis”

Lesson 3 of 11

Unlock all 11 lessons, the quiz, and 1.5 Class A credits. 1.5 of those count toward pharmacology.

More free lessons from this module